Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

HYPERRAB DIN 02486571

Status: Marketed
Holder: GRIFOLS THERAPEUTICS LLC
Molecule: RABIES IMMUNOGLOBULIN (HUMAN)

Health Canada record

Active ingredient(s)RABIES IMMUNOGLOBULIN (HUMAN) 300 UNIT
Dosage formSolution
RouteIntramuscular
ScheduleSCHEDULE D
ClassHuman
ATCJ06BB05 RABIES IMMUNOGLOBULIN
Original market date02-Jul-2019
Current status date02-Jul-2019
SourceHealth Canada DPD

Establishment licence of the holder

Grifols Therapeutics LLC — licence , not currently licensed, last inspection rating C (2023-06-03).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing RABIES IMMUNOGLOBULIN (HUMAN)

DINProductCompanyFormStrengthStatus
02482436KAMRABKAMADA LTDSolutionRABIES IMMUNOGLOBULIN (HUMAN) 150 UNITMarketed
02482509KAMRABKAMADA LTDSolutionRABIES IMMUNOGLOBULIN (HUMAN) 150 UNITApproved
00345733HYPERAB RABIES IMMUNE GLOBULIN HUMANCUTTER MED & BIOL, DIVISION OF MILES CANADA LTD.LiquidRABIES IMMUNOGLOBULIN (HUMAN) 16.5 %Cancelled Post Market
02230700HYPERRAB S/DGRIFOLS THERAPEUTICS LLCSolutionRABIES IMMUNOGLOBULIN (HUMAN) 150 UNITCancelled Post Market
01910477IMOGAM RABIES INJ 150UNIT/MLPASTEUR MÉRIEUX SERUMS ET VACCINS, S.A.LiquidRABIES IMMUNOGLOBULIN (HUMAN) 150 UNITCancelled Post Market
02237328IMOGAM RABIES PASTEURIZEDSANOFI VACCINES CANADA LTD.SolutionRABIES IMMUNOGLOBULIN (HUMAN) 150 UNITCancelled Post Market

Notices of Compliance

NOCDateSubmissionReason
219712019-03-13Supplement to a New Drug Submission (SNDS)CHANGES TO THE MANUFACTURING PROCESS
Request a quote for HYPERRAB

How to read a Canadian DIN record